Osivax

About:

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

Website: http://www.osivax.com/

Top Investors: Bpifrance, European Innovation Council, Bill & Melinda Gates Foundation, Anaxago, National Institute of Allergy and Infectious Diseases

Description:

​Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.